Allgens Medical Technology CO., LTD. (SHA:688613)
China · Delayed Price · Currency is CNY 16.03
+0.24 (1.52%)
Jun 12, 2026, 3:00 PM CST
SHA:688613 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 9.87 | 9.5 | -12.66 | 54.23 | 95.22 | 120.78 |
Depreciation & Amortization | 21.77 | 21.77 | 18.35 | 18.04 | 18.03 | 13.17 |
Other Amortization | 9.43 | 9.43 | 6.46 | 4.87 | 2.28 | 1.58 |
Loss (Gain) From Sale of Assets | -0.46 | -0.46 | -0.64 | - | - | - |
Asset Writedown & Restructuring Costs | -12.89 | -12.89 | -0.2 | -0.08 | 0.32 | 0.01 |
Loss (Gain) From Sale of Investments | -0.12 | -0.12 | -17.92 | -18.02 | -10.23 | -14.92 |
Provision & Write-off of Bad Debts | - | - | 9.23 | 1.42 | 0.61 | 0.48 |
Other Operating Activities | -18.19 | -1.98 | -1.4 | 1.86 | -1.71 | 1.8 |
Change in Accounts Receivable | 29.99 | 29.99 | -21.15 | -30.39 | -12.16 | -9.52 |
Change in Inventory | -22.24 | -22.24 | -22.35 | -12.71 | 0.71 | 1.83 |
Change in Accounts Payable | 2.81 | 2.81 | 25.79 | 38.52 | 11.81 | 16.22 |
Operating Cash Flow | 23.65 | 39.49 | -19.6 | 51.68 | 102.05 | 129.76 |
Operating Cash Flow Growth | - | - | - | -49.36% | -21.35% | 52.89% |
Capital Expenditures | -28.9 | -28.93 | -13.43 | -21.9 | -45.42 | -61.22 |
Sale of Property, Plant & Equipment | 0 | 0 | 0 | 0.21 | 0 | - |
Cash Acquisitions | - | - | -24.62 | - | - | - |
Investment in Securities | -3 | -5 | -3.63 | -96.57 | -152 | -168.8 |
Other Investing Activities | 0.12 | 0.12 | 55.89 | 0.19 | 0.03 | 0.53 |
Investing Cash Flow | -31.78 | -33.8 | 14.22 | -118.08 | -197.39 | -229.49 |
Long-Term Debt Issued | - | - | - | 25 | - | 47.6 |
Long-Term Debt Repaid | - | -4.69 | -10.69 | -40.15 | -15.67 | -56.75 |
Net Debt Issued (Repaid) | -36.25 | -4.69 | -10.69 | -15.15 | -15.67 | -9.15 |
Issuance of Common Stock | 14.71 | 14.71 | 22.52 | - | - | 508.33 |
Common Dividends Paid | -1.94 | -2.28 | -10.78 | -17.06 | -40.12 | -1.24 |
Other Financing Activities | -1.7 | -1.47 | - | - | - | -7.73 |
Financing Cash Flow | -25.19 | 6.26 | 1.05 | -32.22 | -55.79 | 490.21 |
Foreign Exchange Rate Adjustments | 0.19 | 0.4 | -0.2 | 0 | -0.3 | 0 |
Net Cash Flow | -33.14 | 12.35 | -4.54 | -98.62 | -151.43 | 390.49 |
Free Cash Flow | -5.25 | 10.56 | -33.03 | 29.78 | 56.63 | 68.54 |
Free Cash Flow Growth | - | - | - | -47.42% | -17.38% | 140.72% |
Free Cash Flow Margin | -2.28% | 4.72% | -16.03% | 13.15% | 23.09% | 29.04% |
Free Cash Flow Per Share | -0.04 | 0.08 | -0.23 | 0.23 | 0.42 | 0.57 |
Cash Income Tax Paid | 25.38 | 25.38 | 22.93 | 16.52 | 10.57 | 20.5 |
Levered Free Cash Flow | -4.33 | 2.62 | -22.86 | 18.41 | 5.93 | 11.95 |
Unlevered Free Cash Flow | -4.33 | 2.62 | -21.02 | 20.36 | 7.09 | 14.09 |
Change in Working Capital | 14.24 | 14.24 | -20.84 | -10.65 | -2.47 | 6.86 |